Reversible Pisa syndrome associated with switching from haloperidol to aripiprazole during lithium treatment.
Huang
Yu-Chi
YC
Lee
Yu
Y
Lin
Pao-Yen
PY
D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000068180:Aripiprazole; D002739:Chloroquinolinols / Q000627:therapeutic use; D004421:Dystonia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D018020:Lithium Compounds / Q000627:therapeutic use*; D008875:Middle Aged; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000150:complications / Q000188:drug therapy*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use; D013035:Spasm / Q000139:chemically induced
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002739:Chloroquinolinols; D018020:Lithium Compounds; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; C011838:halquinol